Clinical Trials Browser

Phase 2 × prexasertib × 90 days × Clear all

NCT05548296 2026-01-22

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Phase 2 Recruiting

Endometrial Neoplasms